Teleflex has received US Food and Drug Administration (FDA) clearance for the Wa...
Patients with ST-elevation myocardial infarction (STEMI) occurring during th...
Results of the first study of a first-generation drug-coated balloon (DCB) w...
Dasi Simulations has announced it has received US Food and Drug Administration (...
The European Society of Cardiology (ESC) has announced the appointment of Je...
Translumina has announced the acquisition of Munich-based Lamed GmbH, which ...
The US Food and Drug Administration (FDA) has released draft guidance with u...
While the exact location of atherosclerotic plaque ruptures—a common cause of my...
Defibrillators are being used in just one in 10 cardiac arrests where they are a...
Lars Søndergaard has left his role as professor of cardiology at Rigshospitalet,...
Conformal Medical has announced the successful completion of its series D fu...
EnCompass Technologies has announced its novel F2 cerebral embolic filter was us...
Medtronic has announced that Ken Washington has been appointed chief technology ...
Valve Medical, a wholly owned subsidiary of Medinol Ltd, has announced the first...
Discharging patients early after transcatheter aortic valve implantation (TA...
This advertorial is sponsored by Boston Scientific
Stroke—particularly disabl...
New data presented from an investigator-sponsored European trial found managing ...
Thirona recently announced its new artificial intelligence (AI)-based algorithm ...
Cora Therapeutics has announced the presentation of the results of a clinica...
An international clinical trial presented today at the European Stroke Organ...
Implementation of a dedicated training programme allowed hospitals to incre...
Enrolment in the EURO SHOCK trial was curtailed due to the COVID-19 pandemi...
Ticagrelor monotherapy after three months of ticagrelor plus aspirin was ass...
Preliminary results from the BIO-LIBRA study, assessing the outcomes of devi...
Results from a pivotal clinical trial found a leadless pacemaker can deliver...
Inventor of the Valsalva aortic graft Ruggero De Paulis (European Hospital Unica...
In this issue:
A new era for intracoronary imaging
Top trials from ACC 2...
A large registry study of patients undergoing transcatheter edge-to-edge rep...
A novel artificial intelligence (AI) model correctly identified patients at near...
Analysis of the Global SYMPLICITY registry DEFINE (GSR DEFINE), presented at...
Paolo Contessotto (National University of Ireland Galway, Galway, Ireland) outli...
Bentley has announced the US launch of its BeBack crossing catheter, which is de...
A randomised controlled trial comparing the safety of distal versus proximal rad...
Six-month outcomes from FLASH registry have shown that patients with pulmonary e...
Medtronic has announced two-year results for its Harmony transcatheter pulmonary...
Results of the first-in-human study BIOMAG-I study, assessing Biotronik’s la...
Analysis from The North American COVID-19 STEMI (NACMI) registry, presented ...
The Society for Cardiovascular Angiography & Interventions (SCAI) has na...
Elixir Medical has announced that the BIOADAPTOR RCT trial of the company’s ...
New data from the Benchmark Registry, a study of a streamlined transcatheter aor...
A process of flushing prosthetic valves using carbon dioxide (CO2) prior to ...
First-generation bioresorbable vascular scaffolds (BVS) may be just as effec...
A machine learning-based model which uses electronic health record (EHR) dat...
Edwards Lifesciences has announced new data from the COMMENCE aortic trial, ...
A real-world comparison of two techniques aimed at reducing the risk of coro...
Operators performing percutaneous coronary intervention (PCI) in bifurcation...
The use of an image-guidance system that overlays angiographic images on liv...
In this issue:
A new era for intracoronary imaging
Top trials from ACC 2...
Robocath has announced the launch of its latest robotic platform—the R-One+.
...
Shockwave Medical has announced the full commercial availability of the Shockwav...
Foldax has announced that it has executed an agreement with Australia’s nati...
OpSens has announced the inclusion of SavvyWire in the COMPLETE TAVR clinical st...
In a recent study, researchers determined that derivatives of natural emulsi...
Postmenopausal women with clogged arteries are at higher risk of heart attacks t...
This educational supplement, sponsored by Shockwave Medical, gains fresh perspec...
How has the new Shockwave C2+ catheter changed the treatment of calcified co...
Calcified nodules are frequently identified among coronary artery lesions an...
Tom Johnson (University Hospitals Bristol & Weston NHS Foundation Trust,...
Akura Medical announced today it has initiated its first-in-human clinical study...
This advertorial is sponsored by Medtronic
New data offer greater perspec...
This advertorial is sponsored by B Braun Melsungen AG
“The evolution of PCI ...
A recent study has found deep neural networks (DDNs)—a category of artificia...
AstraZeneca’s Farxiga (dapagliflozin) has been approved in the USA to reduce the...
Emboline has announced that the first patient has been treated in the Protect th...
Judges of the CX 2023 Dragon’s Den-style contest — the finale of the Day 3 C...
News highlights this April were brought by Podium First data from the BASIL-...
Vivasure Medical has announced it has enrolled the first patients in the com...
The US Food and Drug Administration (FDA) has granted the third investigational ...
Research has highlighted significant regional variations in the availability...
Ultromics has been granted US Food and Drug Administration (FDA) breakthrough de...
Statin treatment after aortic repair is associated with improved long-term s...
A question from Manj Gohel (Cambridge University Hospitals NHS Foundation Trust,...
Cardiac Dimensions has announced that its Carillon mitral contour system, fo...
Cardialysis, the 40-year old cardiovascular research organisation, based in ...
Pie Medical Imaging has received NINSHO Medical Device Certification for CAAS Qa...
Effective management of depression through psychological therapy is associated w...
Adept Medical has launched the Adducted Arm Scoop—an improved solution for s...
The first transcatheter tricuspid valve replacement procedure in the USA usi...
Deaths from cardiovascular disease are elevated on polluted days and for two day...
Shockwave Medical has announced the completion of its previously announced a...
OpSens has announced the successful completion of enrolment in the SAFE–TAVI cli...
The news agenda in March was dominated by late-breaking data from the American C...
AVS, an early-stage medical device company focused on safely and effectively...
New research will investigate how stretching and blood flow can inhibit or e...
Medtronic has announced the launch of MRI Care Pathway, a new system designed to...
Endotronix has announced its PROACTIVE-HF pivotal study has successfully com...
Wearable devices such as smart watches could be used to detect a higher risk of ...
The UK’s first remotely-supported transcatheter aortic valve implantation (TAVI)...
Cardiovascular Systems has announced the complete enrolment of its 2,000-pat...
The Society for Cardiovascular Angiography & Interventions (SCAI) and th...
Abbott has announced that the US Food and Drug Administration (FDA) has appr...
Supira Medical has announced the appointment of Azeem Latib (Montefiore Heal...
This advertorial is sponsored by Boston Scientific
Today there are more than ...
Results from the PADN-5 study, investigating the efficacy and safety of pulm...
Saranas has announced that it has reached the midpoint for enrolment in SAFE-MCS...
A prospective observational study had found that, in asymptomatic persons, s...
Procyrion, a medical device company which aims to improve outcomes...
Abbott has today announced new data that found monitoring patients...
MedAlliance has announced enrolment of over 1,000 patients in its SELUTION DeNov...
Immediate, complete revascularisation with percutaneous coronary interventio...
Stereotaxis has announced the opening of a new robotic electrophysiology pro...
A total of £10 million has been awarded to the Medicines and Healthcare products...
Merit Medical has announced the expansion of itsSwiftNinja steerable microcathet...
Angiographic and clinical data from the BIOMAG-I clinical study, presented a...
HeartBeam, a cardiac technology company that has developed the three-dimensional...
Vivasure Medical has announced that the US Food and Drug Administration (FDA) ha...
LivaNova has announced the receipt of US Food and Drug Administration (FDA) 510(...
Assessing myocardial viability does not aid the selection of patients who wi...
February’s trending topics included a look at the past, present and future of tr...
A new trial of endovascular ultrasound-based renal denervation technology ha...
Edwards Lifesciences has highlighted new data examining mortality rates and ...
The European Union’s Council of Ministers has today adopted a resolution to exte...
Data from a new prespecified analysis of the phase III VOYAGER PAD clinical ...
Results of the Pulsed AF Pivotal trial, investigating pulsed field ablation ...
The largest randomised controlled trial to date to compare minimally invasiv...
Neovasc has announced that its shareholders have approved the previously-ann...
Use of intravascular imaging guidance for percutaneous coronary intervention (PC...
Large bore mechanical thrombectomy with the FlowTriever system (Inari Medica...
Final, five-year clinical outcomes from the COAPT trial, evaluating transcat...
Three-year results from the Evolut Low Risk trial have shown “durable” benef...
Hotly-anticipated results of the randomised TRILUMINATE pivotal trial, prese...
One-year insights from the bRIGHT registry, detailing real-world results of...
Researchers have detailed a new preclinical model for non-ST elevation myocardia...
Women have been found to have significantly higher risk of operative mortali...
SpectraWAVE has announced US Food and Drug Administration (FDA) 510(k) clearance...
Results from the PORTICO NG study of Abbott’s Navitor transcatheter aortic valve...
ReCor Medical and its parent company, Otsuka Medical Devices, recently annou...
Five-year bioprosthetic valve dysfunction data for Medtronic’s CoreValve and...
Results of a trial involving cell therapy in patients with chronic heart fai...
Results from the CONFORMAL early feasibility study (EFS), evaluating the use...
A model designed to predict surgical risk in the setting of adult congenital hea...
Medtronic has welcomed the publication of the consensus statement on renal dener...
Procyrion has announced the successful treatment of the first patients in the A ...
Disabilities were underreported in clinical trial data and commonly used as a ba...
Medtronic has announced the relaunch of its Harmony transcatheter pulmonary valv...
CVRx has announced the preliminary topline results of the BeAT-HF—Baroreflex act...
RapidAI announced it has received US Food and Drug Administration (FDA) 510(k) c...
The publication of a consensus statement from the European Society of Cardio...
Teleflex Incorporated has today announced key milestones in the release of two n...
A single-centre retrospective study of rehospitalisation after transcathete...
Xeltis has raised €32 million in a Series D2 equity fundraise, backed by a syndi...
NOTE: This video is ONLY available to watch in selected countries and geographie...
The American College of Cardiology (ACC), the American Heart Association (AHA) a...
Renal denervation represents another treatment option in patients with uncontrol...
As transcatheter aortic valve implantation (TAVI) moves beyond its 20-year ...
Sleeping an inconsistent number of hours each night and falling asleep at di...
Attendees of the 2023 Joint Interventional Meeting (JIM, 9–11 February, Milan, I...
SIS Medical AG has announced the launch of its OPN NC percutaneous transluminal ...
GE HealthCare has signed an agreement to acquire Caption Health, a developer...
Abbott and Cardiovascular Systems (CSI) have announced a definitive agreement fo...
A retrospective cohort study has found the likelihood of receiving percutane...
In the opening month of 2023, Cardiovascular News’ most read stories include sex...
This advertorial is sponsored by Cardionovum
“Everything started with bal...
A randomised study led by Greater Manchester Mental Health NHS Foundation Tr...
In this issue:
Medicare study reopens guideline debate around surgery and P...
In this issue:
Medicare study reopens guideline debate around surgery and P...
This advertorial is sponsored by iVascular
A new coronary scoring balloon...
Performance improvement company Biome Analytics has announced the publication of...
TruLeaf Medical is to conduct a first-in-human clinical trial of a “two-stag...
Percutaneous coronary intervention (PCI) without on-site surgical support is as ...
From cutting-edge aortic interventions to consensus on revascularisation strateg...
This advertorial is sponsored by B. Braun Melsungen AG
The modern field o...
AtriCure has announced that the first patient was treated in the LeAAPS clinical...
Trials in coronary imaging, transcatheter tricuspid valve interventions, tra...
Little progress has been made over the last decade in improving gender balance i...
Interventional cardiology is a rapidly evolving field, offering the opportunity ...
An analysis of data from more than 100,000 patients with multivessel coronar...
The first US patient has been enrolled at Medstar Washington Hospital Center (Wa...
BioVentrix, a privately held medical device company focused on the development o...
A group of engineers and physicians have created a wearable ultrasonic devic...
Transcatheter treatment options for aortic regurgitation (AR) bring a new, ...
A study conducted by Michigan Medicine (Ann Arbor, USA) researchers suggests tha...
A new risk assessment tool has been produced to provide a comprehensive meth...
Pie Medical Imaging has announced the enrolment of the 500th patient in the FAST...
Zoll has announced that the first patient has been enrolled in the REAL SSO2 pos...
The largest dedicated registry on mitral transcatheter edge-to-edge repair (...
Shockwave Medical has entered into a definitive agreement to acquire Neovasc...
The US Food and Drug Administration (FDA) has approved the Navitor (Abbott) tran...
Research evaluating the effects of high bleeding risk (HBR) and complex percutan...
Pie Medical Imaging has launched a new version of its echocardiography software ...
Viz.ai has announced the launch of Viz Vascular Suite—artificial intelligenc...
The UK’s National Institute for Health and Care Excellence (NICE) has published ...
HVR Cardio has closed on a €10.7 million series B round of financing. The Se...
Patients with depression were 10–20% less likely to adhere to guideline-directed...
Closer ties between cardiologists, cardiac surgeons and vascular surgeons will b...
Selution SLR, MedAlliance’s novel sirolimus-eluting balloon, has received condit...
A preclinical study demonstrating key features of the foam-based left atrial...
Cardiac Dimensions has closed a US$35 million Series D financing round. The ...
AVS has announced that it raised US$20 million in Series B financing, which the ...
Which stories, features and interviews captured the attention of the cardiovascu...
The Society for Cardiovascular Angiography & Interventions (SCAI) has announ...
Transcatheter tricuspid valve intervention is associated with similar outcom...
ReCor Medical and its parent company Otsuka Medical Devices have announced t...
Anthos Therapeutics has announced that it has enrolled the first patient in ...
Johnson & Johnson has today announced it has completed its acquisition of Ab...
Using machine learning and clinical data from electronic health records, researc...
Researchers have developed ‘stem cell plasters’ which it is hoped will revol...
The first two patients have been enrolled in the Impella ECP pivotal trial, ...
CytoSorbents Corporation has received the recommendation from the independen...
Pi-Cardia has announced that the first patient in the USA has been successfully ...
The current model for randomised clinical trials must be redesigned for the mode...
A first-in-human trial using a purpose-built device to provide direct wire pacin...
Corindus has been rebranded to Siemens Healthineers Endovascular Robotics an...
In a recent study which revealed higher readmission and mortality rates amon...
Europe’s health commissioner, Stella Kyriakides, has announced that proposal...
AstraZeneca has today announced that the Medicines and Healthcare products Regul...
TRiCares has announce the second closing and completion of its Series C financin...
Corvia Medical has announced that the first patient has been randomised in R...
A new method for determining whether patients with heart disease need corona...
The European Society of Cardiology (ESC) has urged European Union (EU) health mi...
The addition of an annular sealing skirt, among other design changes in the ...
One-year results from the TRISCEND study, investigating the Evoque (Edwards ...
This advertorial is sponsored by Medtronic
Durability, reliability, accur...
The Swiss Federal Assembly has voted in favour of accepting medical devices with...
Otsuka Medical Devices and ReCor Medical, a subsidiary of Otsuka, ...
Anteris Technologies has announced that the US Food and Drug Administration (FDA...
inQB8 Medical Technologies, in partnership with Peijia Medical, has announce...
Nyra Medical has announced the closing of a US$20 million Series A financing...
The first implant procedure using the Impella RP Flex (Abiomed) percutaneous pum...
A retrospective analysis of data collected from the Blue Cross Blue Shield of Mi...
Data presented at an innovation session at the 2022 Structural and Coronary Inte...
A pioneer of one of the first regional ST-segment elevation myocardial infarctio...
Carmat has announced the resumption of commercial implants of its Aeson total ar...
CroíValve has announced the successful first in human implants of its Duo tr...
In this issue:
Latest evidence from key renal denervation trials
REVIVED...
In this issue:
Latest evidence from key renal denervation trials
REVIVED...
Extended follow-up of the ISCHEMIA-EXTEND trial has shown no difference in r...
Viz.ai has announced a partnership with Illuminate, a developer of proprietary n...
Bivalirudin is a safer and more effective anticoagulant than heparin for treatin...
Soundbite Medical Solutions announced that it has entered into an exclusive lic...
CVRx—the developer of the “world’s first” US Food and Drug Administration (FDA)-...
Mentice has announced that Siemens Healthineers China is showcasing the remote c...
Patients at high risk for acute kidney injury (AKI), the most common complicatio...
WL Gore & Associates has announced that it is initiating the RELIEF clin...
Neovasc has announced that the Centers for Medicare and Medicaid Services (CMS) ...
ReCor Medical and its parent company, Otsuka Medical Devices, announced cons...
Medtronic has announced the six-month results from the full cohort of the SP...
The first results from the BEST-CLI randomised controlled trial (RCT) of 1,8...
The American College of Cardiology (ACC) and American Heart Association (AHA) ha...
Johnson & Johnson is to acquire Abiomed, it was announced today, after the t...
Abiomed has announced that Impella RP Flex with SmartAssist has received US Food...
Transit Scientific has announced that the XO RX 2.2Fr and XO RX 3.8Fr platform h...
The application of new technologies and techniques to treat challenging and ...
This session really reminds clinicians that the answer is not always an intervention in 100% of patients.
Heinz Jakob (Essen, Germany) and Tilo Kölbel (Hamburg, Germany) offer their ...
Carmat, developer of the Aeson total artificial heart, has announced that it...
Abiomed has announced the US Food and Drug Administration (FDA) has accepted...
OpSens Medical has announced the successful completion of the first cases in a c...
Bruce Ovbiagele, associate dean and professor of neurology at the University...
Selution SLR, MedAlliance’s novel sirolimus-eluting balloon, has received US Foo...
In patients undergoing coronary artery bypass graft (CABG) surgery, the addi...
Researchers are to investigate the safety and efficacy of performing left at...
AccurKardia, a software company that provides clinical-grade, device agnostic, a...
HeartFlow has received US Food and Drug Administration (FDA) 510(k) clearanc...
MedAlliance is to be acquired by Cordis, it was announced today, after the two c...
In a large, population-based study of patients with atrial fibrillation (AF) and...
The US Food and Drug Administration (FDA) has granted 510(k) clearance to Ab...
An analysis of data from the Swedish Coronary Angiography and Angioplasty Re...
An analysis of more than 2,000 patients from a large US real-world database ...
The Uppsala Clinical Research Center (UCR) and the European Cardiovascular R...
The developers of a cannula for minimally-invasive central aortic perfusion—...
CathWorks has announced approval of the fourth generation CathWorks FFRangio...
A global research initiative will compare coronary artery bypass graft surge...
The chance of a patient surviving after an acute type A aortic dissect...
Clinical trials in cardiothoracic surgery must ensure that sufficient number...
Ajay Kirtane (Columbia University Irving Medical Center New York-Presbyteria...
Results of the FLASH registry demonstrate the “excellent safety profile” of ...
Three-year outcomes from the SMART-CHOICE trial have shown that P2Y12 inhibitor ...
ABILITY DIABETES-GLOBAL, a randomised controlled head-to-head trial comparing sa...
Puzzle Medical Devices was announced as the winner of the Shark Tank innovation ...
The use of rivaroxaban for seven days after a transradial coronary procedure...
Results of a new per-protocol analysis of the ST-segment Elevation Myocardia...
OpSens has announced that Philippe Genereux (Morristown Medical Center, Morristo...
Biotronik has announced the presentation of new full-cohort two-year BIOSOLV...
Medtronic has received Food and Drug Administration (FDA) approval for the treat...
JenaValve Technology has announced the successful completion of patient enrolmen...
Analysis of data from the Society of Thoracic Surgeons/American College of C...
Results from a multicentre randomised trial comparing ultrasound with fluoro...
Medtronic has announced the expanded US market release of its newest-generation,...
Shockwave Medical has initiated a prospective coronary intervention study consis...
Advanced NanoTherapies has been granted US Food and Drug Administration (FDA...
Long-term follow-up of patients with non-valvular atrial fibrillation (AF) r...
Findings from the RADIANCE II randomised pivotal trial, presented at the 202...
The major contribution of Valentin Fuster (Mount Sinai Health System, New Yo...
The first randomised trial to compare two transcatheter edge-to-edge repair ...
Among patients undergoing transfemoral transcatheter aortic valve implantati...
OpSens has received 510(k) regulatory clearance from the US Food & Drug Admi...
The 2022 Transcatheter Cardiovascular Therapeutics (TCT, 16–19 September, Bo...
Abiomed has announced two approvals from the US Food and Drug Administration (FD...
Edwards Lifesciences has announced that its Pascal Precision transcatheter valve...
Teleflex has announced that Magnus Settergren, associate professor at the Karoli...
Cardiac Implants has announced the successful initial deployment of its annulopl...
Concept Medical has announced the successful completion of the TRANSFORM 1 R...
A budget impact analysis comparing transcatheter aortic valve implantation (...
Haemonetics Corporation has received CE mark certification for its Vascade v...
Edwards Lifesciences has announced the launch of the Sapien 3 Ultra Resilia valv...
Abbott has announced three-year data for its Amplatzer Piccolo occluder for the ...
Analysis of the global make-up of the four largest global societies for cardioth...
Results of an analysis of Aktiia’s cuffless blood pressure (BP) monitoring syste...
Zoll Medical has announced that the first patient has been enrolled in the AMIHO...
Abbott has announced the European launch of its Amplatzer Talisman patent forame...
AtriAN Medical has announced that it has completed enrolment of a second study u...
As a proponent of minimally invasive cardiac surgery and transcatheter technique...
The most read stories from across Cardiovascular News in August 2022 include hig...
Viz.ai has received US Food and Drug Administration (FDA) 510(k) clearance for a...
Royal Philips has announced that Baptist Health’s Miami Cardiac & Vascular I...
Boston Scientific has received US Food and Drug Administration (FDA) approva...
Andrew Wigham (Oxford, UK) and Rick De Graaf (Friedrichshafen, Germany) dis...
Cardionovum has announced the enrolment of the first patient in the internat...
JenaValve Technology has announced that it has completed the initial closing of ...
Researchers have developed a risk score to predict mortality for patients wi...
Abbott has announced the release of late-breaking showing that its HeartMate...
Transradial access for percutaneous coronary procedures is associated with l...
Fifteen-month results from the MASTER DAPT trial have shown that the preserv...
In patients with advanced chronic kidney disease (CKD) and chronic coronary ...
Selection of non-infarct related artery (IRA) lesions for intervention using...
Late-breaking research presented at the European Society of Cardiology (ESC)...
Among high-risk patients undergoing percutaneous coronary intervention (PCI)...
Results of one of the first and only randomised, blinded trials to assess th...
Percutaneous coronary intervention (PCI) does not reduce all-cause mortality...
Use of a ‘polypill’ after myocardial infarction (MI)—an all-in-one pill cont...
ŌNŌCOR has announced in a company press release that the ŌNŌ endovascular retrie...
The timing of dosing of antihypertensive medication—whether it is taken in t...
The Cardiovascular Research Foundation (CRF) and Fogarty Innovation have ann...
Medtronic has announced the launch of its latest generation drug-eluting coronar...
In this issue:
Call for action over age and gender profile of global cardio...
In this issue:
Call for action over age and gender profile of global cardio...
Miracor Medical has announced the approval of an investigational device exem...
Pi-Cardia has announced a successful first-in-human treatment of the mitral valv...
Edwards Lifesciences has announced that the company's Pascal Precision trans...
Abiomed has announced the results of the Restore EF study, demonstrating that I...
CX Aortic Vienna returns in October for its third edition (24–26 October, Digita...
The American Heart Association (Association) and the Cardiovascular Research Fou...
Ongoing clinical trials looking at transcatheter aortic valve implantation (...
The most read stories from across Cardiovascular News in July 2022 include refle...
Projected rates of cardiovascular risk factors and disease will increase signifi...
Thubrikar Aortic Valve has announced successful 30-day outcomes in the first two...
Cardiac surgeons from North America, Europe and Latin America are among the sign...
A project to develop genetic therapies to effectively cure cardiomyopathy ha...
iVascular has announced the release of three-year observational data concerning ...
Neovasc has announced that the US Food and Drug Administration (FDA) has app...
Centese has announced the publication of the first peer-reviewed clinical study ...
Pi-Cardia has received Investigational Device Exemption (IDE) approval from the ...
ReCor Medical and Otsuka Medical Devices have announced that the RADIANCE II US ...
Incentives for the enrolment of patients from socieconomically disadvantaged...
Cathbot—a joint venture between Robocath and MicroPort—has enrolled the last pat...
Preventing coronary obstruction after transcatheter aortic valve implantatio...
A research project at the University of Leeds (Leeds, UK) aiming to find an ...
Ancora Heart has announced that the US Food and Drug Administration (FDA) ha...
Intratech Medical has announced the successful enrolment of two patients in a mu...
The VenusP-Valve (Venus Medtech) transcatheter pulmonic valve replacement (T...
Medtronic today announced it has entered into a strategic partnership agreement ...
Patients identified by nuclear stress testing as having severe stress-induce...
Transcatheter aortic valve implantation (TAVI) will continue to spread acro...
Echocardiographers may be at significantly greater risk of exposure to radiation...
The Cardiovascular Research Foundation (CRF) and Fogarty Innovation have announc...
A subgroup analysis of the BIO-RESORT trial has shown a “trend towards bette...
HeartBeam is expanding the available patient population for its emergency depart...
The most read stories from across Cardiovascular News in June 2022 include highl...
Suzanne Baron and Ki Park detail some of the barriers facing women in the fi...
Advanced NanoTherapies has closed a US$7.2 million Series A equity financing...
Results from the first commercial implants of the Trilogy transcatheter aort...
Teleflex has announced the first patient enrolment in a clinical study that ...
People who develop an arrhythmia after surgery have an increased risk of subsequ...
Acutus Medical has announced the commercial launch of an expanded suite of l...
A retrospective study from Kubkin Choi and researchers from Mayo Clinic (Rochest...
SoniVie recently announced that on 5 May 2022 the US Food and Drug Administratio...
Conformal Medical has announced the launch of the CONFORM pivotal trial with...
The National Institute for Health and Care Excellence (NICE) has recommended...
Dual antiplatelet therapy (DAPT) after left atrial appendage occlusion (LAAO...
Transcatheter aortic valve implantation (TAVI) with the Acurate neo2 (Boston...
Analysis of the EXPAND registry, looking at one-year outcomes of MitraClip t...
Data from the first report on patients with a pacemaker lead across the tric...
AtriCure has announced that the first patient has been treated in the HEAL-IST t...
The potential to utilise artificial intelligence (AI) or machine learning in c...
This advertorial is sponsored by Adept Medical.
Outlining Adept Medical’s pro...
A retrospective review of more than 24,000 patients who underwent an electrocard...
Filterlex Medical has announced results from a first-in-human (FIH) study de...
A study has revealed the “global collateral damage” caused by the disruption to ...
A new consensus statement—in development from the European Society of Cardi...
“At the moment, tricuspid is the valve where most things are happening,” sa...
Transcatheter aortic valve implantation (TAVI) was found to be non-inferior ...
The use of distal radial artery access for percutaneous coronary interventio...
Concurrent tricuspid valve surgery and left ventricular assist device (LVAD)...
Robotic-assisted percutaneous coronary intervention (PCI) has the potential...
New data confirming one-year outcomes with coronary intravascular lithotrips...
Sunil Rao (Duke University Health System, Durham, USA) has assumed the offic...
Endotronix has announced data from the SIRONA 2 clinical trial evaluating sa...
Shockwave Medical and Genesis MedTech Group announced today that they have succe...
Adept Medical says it has responded to the call from interventional radiolog...
Transcatheter tricuspid valve repair potentially offers a “less risky” opti...
One-year outcomes of the CLASP TR study, investigating the use of the Pascal (Ed...
Matti Adam (Cologne, Germany) talks to Cardiovascular News about the evolut...
Use of the cusp overlap technique for the deployment of devices in transcath...
Results of the 20-patient, first-in-human clinical study supporting the safety a...
Patients in England with ST-elevation myocardial infarction (STEMI) had an a...
“Renal denervation has travelled a very storied path over the last 10–15 ye...
Analysis of data from a US-wide health system suggests that the volume of percut...
Biotronik has shared new data presented at EuroPCR 2022 (17–20 May, Paris, F...
New data on robotic-assisted percutaneous coronary intervention (PCI) have been ...
Vivasure Medical has announced the closing of the first tranche of €22 million (...
Analysis of the MASTER DAPT trial, presented as a late-breaking trial at EuroPCR...
Late-breaking trial data presented at EuroPCR 2022 (17–20 May, Paris, France...
Medtronic has announced that it has received US Food and Drug Administration (FD...
In this issue:
New data hint at positive performance of TAVI on structural ...
In this issue:
New data hint at positive performance of TAVI on structural ...
A US analysis comparing trends in transcatheter and surgical mitral valve repair...
Abbott has announced a new partnership with Women as One to launch a new program...
Vijay Kunadian (Newcastle University and Newcastle upon Tyne Hospital NHS Founda...
This advertorial is sponsored by Siemens Healthineers
In the modern cath lab,...
This advertorial is sponsored by Medtronic
Due to the growth of transcath...
The most read stories from across Cardiovascular News in April 2022 include high...
At the 2022 Charing Cross (CX) International Symposium (26–28 April, London,...
This educational supplement, sponsored by Medtronic, explores the science underp...
In the history of transcatheter aortic valve implantation (TAVI), 16 April 2002 ...
OpSens has announced that it has received Health Canada approval for the SavvyWi...
Biosensors International Group has announced both the Japanese Pharmaceutica...
Medtronic has announced the first patient enrolment in the EXPAND TAVR II pi...
Medtronic has announced that Laura Mauri has been appointed as the company’s chi...
The Society for Cardiovascular Angiography & Interventions (SCAI) has releas...
Translumina has announced the launch of Vivo Isar, its latest generation dual dr...
The pandemic saw a boom in the use of remote technologies and telehealth for...
Corindus, a Siemens Healthineers company, announced today the opening of its new...
Transit Scientific has announced US Food and Drug Administration (FDA) clear...
Quest International and CathWorks have announced a strategic partnership. Qu...
Viz.ai has raised a US$100 million funding round at a US$1.2 billion valuation, ...
Venus Medtech's transcatheter pulmonic valve replacement (TPVR) system—Venus...
CeloNova BioSciences has announced the strategic decision to focus its core ...
Patients treated with edoxaban for six months after a transcatheter aortic v...
The most read stories from across Cardiovascular News in March 2022 include a we...
FEops has announced that it received authorisation from the US Food and Drug...
Abiomed has announced that the first patient in Japan has been treated succe...
Biosensors International has announced the enrolment of the first patient in the...
Patients who received a transcatheter supra-annular self-expanding heart valve h...
Latest results from the North American COVID-19 STEMI (NACMI) registry repor...
A head-to-head comparison of fractional flow reserve (FFR) and intravascular ult...
